TOP PAGE
ENGLISH
JAPANESE
|
CONNECT WITH US:
Home
About
Services
Contact
Log in
Home
Press release
Jun 02, 2023 12:20 JST
Source:
Eisai
Eisai to Present Latest Data on Lemborexant at the 37th Annual Sleep 2023 Meeting
TOKYO, Jun 02, 2023 - (JCN Newswire) - Eisai Co., Ltd. announced a total of eight poster presentations, including the latest data on its in-house discovered orexin receptor antagonist lemborexant (product name: DAYVIGO), will be given at the 37th annual meeting of the Associated Professional Sleep Societies (SLEEP 2023), to be held from June 3 to 7, 2023 in Indianapolis, IN, the United States.
Major poster presentations include new data about the effects of lemborexant on obstructive sleep apnea (poster numbers: #298, 299 and 300).
Eisai considers neurology, including insomnia, a therapeutic area of focus. Eisai strives to create innovative products as soon as possible in therapeutic areas with high unmet medical needs, and will further contribute to addressing the diverse needs of, as well as increasing the benefits provided to, those living with neurological diseases and their families.
About Lemborexant (product name: DAYVIGO)
Lemborexant, an orexin receptor antagonist, is Eisai's in-house discovered and developed small molecule that inhibits orexin neurotransmission by binding competitively to the two subtypes of orexin receptors (orexin receptor 1 and 2). Fast on/off receptor kinetics of lemborexant to orexin receptors may influence lemborexant's potential to facilitate improvements in sleep onset and maintenance with minimal morning residual effects. It has been approved for the treatment of insomnia in over 15 countries including Japan, the United States, Canada, Australia and countries in Asia.
For more information, visit www.eisai.com/news/2023/news202340.html.
Media Inquiries:
Public Relations Department
Eisai Co., Ltd.
+81-(0)3-3817-5120
Eisai Inc. (U.S.)
TEL: +551-305-0050
Christopher_Vancheri@eisai.com
Source: Eisai
Sectors: BioTech
Copyright ©2023 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Related Press Release
Eisai Launches New "Innovation" Page on Corporate Website
September 28 2023 16:05 JST
Tokio Marine Nichido and Eisai Co-Develop Industry's First "Dementia Care Support Insurance"
September 28 2023 13:49 JST
"LEQEMBI Intravenous Infusion" (Lecanemab) Approved for the Treatment of Alzheimer's Disease in Japan
September 25 2023 14:17 JST
Eisai: Release of Dementia Disease Awareness Videos for World Alzheimer's Day, September 21
September 21 2023 11:26 JST
Eisai Establishes Theoria Technologies Co., Ltd., A New Digital Business Company To Build A Dementia Ecosystem
September 12 2023 18:05 JST
Eisai Listed for 22nd Consectutive Year In FTSE4Good Index Series, An Index for Socially Responsible Investment
August 04 2023 12:04 JST
Eisai Presents Latest Analysis of Lecanemab's Effect on Biomarker Changes and Subcutaneous Dosing at The Alzheimer's Association International Conference (AAIC) 2023
July 20 2023 10:23 JST
Eisai to Present the Latest Alzheimer's Disease Pipeline and Research
July 12 2023 09:05 JST
Eisai: FDA Grants Traditional Approval for LEQEMBI (lecanemab-irmb) for the Treatment of Alzheimer's Disease
July 07 2023 12:21 JST
New NEURii Research Collaboration Between Eisai, Gates Ventures, Health Data Research UK, Lifearc and The University of Edinburgh to Develop Digital Solutions for Dementia is Announced
June 30 2023 10:08 JST
More Press release >>
Latest Press Release
PHOENIX HARMONIA, A Very Large LPG/Ammonia Carrier Constructed by Namura Shipbuilding, Enters into Service
Sep 29, 2023 17:11 JST
Stylish, Sporty, Spacious and All-Electric: Honda Prologue SUV Available Early Next Year with Anticipated EPA Range Rating of 300 Miles
Sep 29, 2023 14:31 JST
MHI Thermal Systems Scores Highly Again with Air-Conditioners for Australia and New Zealand Markets
Sep 29, 2023 11:51 JST
World's Best Honda Motorcycle Technician to be Determined at Inaugural Honda Global Motorcycle Technician Contest
Sep 29, 2023 11:05 JST
Eisai Launches New "Innovation" Page on Corporate Website
Sep 28, 2023 17:05 JST
Tokio Marine Nichido and Eisai Co-Develop Industry's First "Dementia Care Support Insurance"
Sep 28, 2023 14:49 JST
NEC sets record for 800 Gbps long-distance transmission over an optical submarine cable system
Sep 28, 2023 13:56 JST
JCB launches a special offer program in Hokkaido for inbound tourist to Japan
Sep 28, 2023 13:00 JST
OREX Announces OREX Open RAN Service Lineup
Sep 27, 2023 14:33 JST
Toyota and Woven by Toyota to Strengthen Ties Toward Accelerating Software Implementation
Sep 27, 2023 13:11 JST
Fujitsu delivers O-RAN ALLIANCE-compliant 5G virtualized RAN solution for NTT DOCOMO's 5G commercial network services
Sep 27, 2023 10:32 JST
DOCOMO to Transfer Ownership of 1,552 Telecommunication Towers to JTOWER to Promote Infrastructure Sharing
Sep 27, 2023 10:03 JST
MHI and ZutaCore Join Forces in a Strategic Alliance, Paving the Way for a Zero-emission Data Industry
Sep 27, 2023 09:00 JST
Overview of Honda Exhibits at the JAPAN MOBILITY SHOW 2023
Sep 26, 2023 17:25 JST
Fujitsu launches new technologies to protect conversational AI from hallucinations and adversarial attacks
Sep 26, 2023 11:02 JST
Fujitsu and iSurgery launch bone health promotion project in Japan with Jikei University School of Medicine aiming for early detection of osteoporosis
Sep 26, 2023 10:20 JST
Mitsubishi Motors to Showcase a Fulfilling Mobility Lifestyle that Awakens Drivers' Adventurous Spirit at the Japan Mobility Show 2023
Sep 25, 2023 17:50 JST
"LEQEMBI Intravenous Infusion" (Lecanemab) Approved for the Treatment of Alzheimer's Disease in Japan
Sep 25, 2023 15:17 JST
Value Research Center (VRC) at SSUNGA78: 'How Purpose, Value, and Impact will Drive a Sustainable Post-SDG Future'
Sep 25, 2023 03:00 JST
TOYOTA GAZOO Racing returns to South American roads
Sep 22, 2023 18:26 JST
More Latest Release >>